Summary Highlights:
- Cresco Labs (CRLBF, Financial) posted a robust Q1 with $166 million in revenue, hitting targets.
- Strategic focus on cash generation and robust market presence in Pennsylvania and Ohio.
- Analysts predict significant upside potential with an average price target of $3.00.
Cresco Labs: A Strong Start to the Year
Cresco Labs Inc. (CRLBF) reported an impressive first quarter, delivering $166 million in revenue, which aligned with market expectations. The company's strategic emphasis on cash generation and maintaining a strong balance sheet has been paying off. This is reflected in the $82 million in adjusted gross profit reported for the quarter, alongside notable market share expansion in Pennsylvania and Ohio.
Wall Street Analysts Forecast for Cresco Labs
According to the latest one-year price targets set by analysts, Cresco Labs Inc. (CRLBF, Financial) is expected to reach an average price of $3.00. This target is consistent across high and low estimates, signaling an anticipated upside of 393.02% from the current trading price of $0.61. For further insights, visit the Cresco Labs Inc (CRLBF) Forecast page.
Brokerage firm assessments suggest a positive outlook, with Cresco Labs Inc. receiving an average recommendation of 2.1. This places the stock in the "Outperform" category on a scale where 1 indicates a Strong Buy and 5 a Sell.
GuruFocus Evaluation: GF Value Insight
According to GuruFocus estimates, the projected GF Value for Cresco Labs Inc. in one year stands at $1.41. This signifies a potential upside of 131.72% from its current price of $0.6085. The GF Value represents GuruFocus’ estimation of the stock’s fair value, determined by assessing historical trading multiples, historical growth patterns, and future business performance projections. More comprehensive data is available on the Cresco Labs Inc (CRLBF, Financial) Summary page.
